Submit your email to push it up the queue
Sherlock Biosciences, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States. Founded in 2019, the company has rapidly established itself as a leader in the development of CRISPR-based diagnostic tools and solutions. With a focus on revolutionising molecular diagnostics, Sherlock Biosciences offers unique products that leverage advanced CRISPR technology for rapid and accurate detection of pathogens and genetic mutations. The company’s flagship offerings, including the Sherlock™ platform, stand out for their precision and ease of use, catering to both clinical and research applications. Notable achievements include significant partnerships and collaborations that enhance its market position, making Sherlock Biosciences a key player in the evolving landscape of healthcare innovation. With a commitment to improving global health outcomes, the company continues to push the boundaries of what is possible in diagnostics.
How does Sherlock Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sherlock Biosciences, Inc.'s score of 25 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sherlock Biosciences, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formalised commitments towards carbon neutrality or emissions reduction. However, it is important to note that emissions data may be cascaded from its parent company, OraSure Technologies, Inc., at a current subsidiary level. This means that while Sherlock Biosciences may not have its own emissions data, it could potentially align with the sustainability initiatives and targets set by OraSure Technologies. As of now, without specific emissions data or reduction targets, Sherlock Biosciences' climate commitments remain unclear. The company may benefit from adopting industry-standard climate strategies to enhance its environmental impact and align with broader corporate sustainability goals.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sherlock Biosciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.